Brian G. Lloyd - Feb 26, 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Brian G. Lloyd
Stock symbol
MMSI
Transactions as of
Feb 26, 2022
Transactions value $
-$126,288
Form type
4
Date filed
3/1/2022, 07:13 PM
Previous filing
Feb 14, 2022
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +6.63K +136.81% $0.00 11.5K Feb 26, 2022 Direct F1
transaction MMSI Common Stock, No Par Value Tax liability -$126K -1.94K -16.92% $65.03 9.53K Feb 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Award $0 +8.09K $0.00 8.09K Feb 26, 2022 Common Stock 8.09K $65.03 Direct F2
holding MMSI Non-qualified stock options (right to buy) 9.68K Feb 26, 2022 Common Stock 9.68K $56.25 Direct F3
holding MMSI Non-qualified stock options (right to buy) 30K Feb 26, 2022 Common Stock 30K $28.20 Direct F4, F5
holding MMSI Non-qualified stock options (right to buy) 25K Feb 26, 2022 Common Stock 25K $44.80 Direct F6
holding MMSI Non-qualified stock options (right to buy) 30K Feb 26, 2022 Common Stock 30K $55.73 Direct F7
holding MMSI Non-qualified stock options (right to buy) 16.7K Feb 26, 2022 Common Stock 16.7K $37.71 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020.
F2 Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
F3 Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
F4 Become exercisable in equal annual installments of 20% commencing on 04/14/2018.
F5 The Form 5 filed on 02/14/2022 incorrectly reported the underlying shares for this holding.
F6 Become exercisable in equal annual installments of 20% commencing on 03/02/2019.
F7 Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
F8 Become exercisable in equal annual installments of 25% commencing on 02/26/2021.